Martina Kovac

1.5k total citations
14 papers, 180 citations indexed

About

Martina Kovac is a scholar working on Epidemiology, Microbiology and Pharmacology. According to data from OpenAlex, Martina Kovac has authored 14 papers receiving a total of 180 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 6 papers in Microbiology and 2 papers in Pharmacology. Recurrent topics in Martina Kovac's work include Bacterial Infections and Vaccines (6 papers), Herpesvirus Infections and Treatments (4 papers) and Pneumonia and Respiratory Infections (4 papers). Martina Kovac is often cited by papers focused on Bacterial Infections and Vaccines (6 papers), Herpesvirus Infections and Treatments (4 papers) and Pneumonia and Respiratory Infections (4 papers). Martina Kovac collaborates with scholars based in United States, Belgium and Slovakia. Martina Kovac's co-authors include Thomas C. Heineman, Himal Lal, Laura Cámpora, Priya Diana Crasta, Karin Hardt, Daniel Shu, Olivier Godeaux, Martine Douha, Robert W. Johnson and Anthony L. Cunningham and has published in prestigious journals such as Pain, Vaccine and Biomedicine & Pharmacotherapy.

In The Last Decade

Martina Kovac

12 papers receiving 176 citations

Peers

Martina Kovac
Martina Kovac
Citations per year, relative to Martina Kovac Martina Kovac (= 1×) peers Raunak Parikh

Countries citing papers authored by Martina Kovac

Since Specialization
Citations

This map shows the geographic impact of Martina Kovac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martina Kovac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martina Kovac more than expected).

Fields of papers citing papers by Martina Kovac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martina Kovac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martina Kovac. The network helps show where Martina Kovac may publish in the future.

Co-authorship network of co-authors of Martina Kovac

This figure shows the co-authorship network connecting the top 25 collaborators of Martina Kovac. A scholar is included among the top collaborators of Martina Kovac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martina Kovac. Martina Kovac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kim, Joon Hyung, Robert W. Johnson, Martina Kovac, et al.. (2022). Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trials. Pain. 164(4). 741–748. 9 indexed citations
2.
Kovac, Martina, Himal Lal, Anthony L. Cunningham, et al.. (2018). Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trials. Vaccine. 36(12). 1537–1541. 34 indexed citations
3.
Kovac, Martina, Lusiné Kostanyan, Narcisa Mesaros, Sherine Kuriyakose, & Meera Varman. (2018). Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study. Human Vaccines & Immunotherapeutics. 14(8). 1977–1986. 12 indexed citations
4.
Ikematsu, Hideyuki, et al.. (2018). Efficacy, Safety and Immunogenicity of a Novel Adjuvanted Subunit Herpes Zoster Vaccine in Japanese Aged 50 Years and 70 Years and Older. Kansenshogaku zasshi. 92(2). 103–114. 5 indexed citations
5.
Godeaux, Olivier, Martina Kovac, Daniel Shu, et al.. (2017). Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial. Human Vaccines & Immunotherapeutics. 13(5). 1051–1058. 45 indexed citations
8.
Essen, Gerrit A. van, Jiřı́ Beran, Jeanne‐Marie Devaster, et al.. (2014). Influenza symptoms and their impact on elderly adults: randomised trial of AS03‐adjuvanted or non‐adjuvanted inactivated trivalent seasonal influenza vaccines. Influenza and Other Respiratory Viruses. 8(4). 452–462. 22 indexed citations
9.
Kovac, Martina, et al.. (2014). Livsfrågepedagogik, En kvalitativ studie om lärares arbete med barns livsfrågor i grundskolan. The Pedagogy of Existential Questions, A qualitative study of teachers work with children in primary school life issues.. KTH Publication Database DiVA (KTH Royal Institute of Technology).
10.
Benca, Juraj, et al.. (2007). Nosocomial meningitis caused by Enterobacteriaceae: risk factors and outcome in 18 cases in 1992-2007.. PubMed. 28 Suppl 2. 27–9. 3 indexed citations
11.
Ondrusova, A, et al.. (2007). Is combination therapy with betalactam plus aminoglycoside (AGL) improving the outcome of nosocomial meningitis in children?. PubMed. 28 Suppl 2. 17–8. 1 indexed citations
12.
Líšková, Anna, et al.. (2007). Antimicrobial susceptibility of cerebrospinal isolates from patients with meningitis.. PubMed. 28 Suppl 3. 5–6.
13.
Cornélissen, Germaine, Franz Halberg, Martina Kovac, et al.. (2005). Geographic and extraterrestrial aspects of morbidity and/or mortality patterns from myocardial infarction and stroke. Biomedicine & Pharmacotherapy. 59. S68–S75. 7 indexed citations
14.
Kovac, Martina, et al.. (2005). Secular rhythms and Halberg's paraseasonality in the time occurrence of cerebral stroke.. PubMed. 106(12). 423–7. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026